Analyst Ratings for Atrium Therapeutics (RNA)
RNA Rating Summary
RNA Price Target Summary
- Highest: $74.00 (TD Cowen)
- Lowest: $15.00 (Roth/MKM)
- Average: $49.91
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$49.91 (+508.6%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 60%
Avg. $ Target:
$49.91 (+508.6%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 60%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/22/2026 | Roth/MKM | Boobalan Pachaiyappan | New Coverage | Buy (N/A) |
15.00 (N/A) |
7.98 (8.20) |
2.76% | Details |
| 8/6/2026 | H.C. Wainwright | N/A | New Coverage | Buy (N/A) |
25.00 (N/A) |
11.74 (8.20) |
-30.15% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
